During the past decade, Viridae Clinical Sciences / University of British Columbia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Viridae Clinical Sciences / University of British Columbia" are "HIV Infections" (2 trials). Many other conditions were trialed in "Viridae Clinical Sciences / University of British Columbia" in a lesser frequency.

Most popular intervention types in "Viridae Clinical Sciences / University of British Columbia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (2 trials), "Efavirenz" (2 trials), "Stavudine" (2 trials), "Abacavir sulfate" (1 trials) and "Aldesleukin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Viridae Clinical Sciences / University of British Columbia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Viridae Clinical Sciences / University of British Columbia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Viridae Clinical Sciences / University of British Columbia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Viridae Clinical Sciences / University of British Columbia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".